Literature DB >> 31925458

PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.

L M Mittlmeier1,2, M Unterrainer2,3, A Todica2, C C Cyran3, S Rodler1, P Bartenstein2, C G Stief1, H Ilhan2, M Staehler4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31925458     DOI： 10.1007/s00259-019-04636-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  68Ga-PSMA-11 PET/CT Parameter Correlates with Pathological VEGFR-2/PDGFR-β Expression in Renal Cell Carcinoma Patients.

Authors:  Jie Gao; Longxiyu Meng; Qinfeng Xu; Xiaozhi Zhao; Yongming Deng; Yao Fu; Suhan Guo; Kuiqiang He; Jiong Shi; Feng Wang; Shiwei Zhang; Hongqian Guo
Journal:  Mol Imaging Biol       Date:  2022-04-22       Impact factor: 3.484

2.  Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer.

Authors:  Simon Sirtl; Andrei Todica; Harun Ilhan; Michal Zorniak; Peter Bartenstein; Julia Mayerle
Journal:  Diagnostics (Basel)       Date:  2021-01-15

3.  [68 Ga]Ga-Prostate-Specific Membrane Antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma.

Authors:  Jolanta Kunikowska; Bartosz Cieślak; Beata Gierej; Waldemar Patkowski; Leszek Kraj; Marcin Kotulski; Krzysztof Zieniewicz; Leszek Królicki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-03       Impact factor: 9.236

4.  PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings.

Authors:  Falk Gühne; Philipp Seifert; Bernhard Theis; Matthias Steinert; Martin Freesmeyer; Robert Drescher
Journal:  Diagnostics (Basel)       Date:  2021-06-23

5.  Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on 18F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression.

Authors:  Lena M Mittlmeier; Stephan T Ledderose; Melanie Schott; Matthias Brendel; Leonie Beyer; Sebastian Theurich; Doris Mayr; Christoph Walz; Wolfgang G Kunz; Jens Ricke; Peter Bartenstein; Harun Ilhan; Michael Staehler; Marcus Unterrainer
Journal:  Diagnostics (Basel)       Date:  2021-03-03

Review 6.  PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports.

Authors:  M J M Uijen; Y H W Derks; W A M van Gemert; J Nagarajah; R I J Merkx; M G M Schilham; J Roosen; B M Privé; S A M van Lith; C M L van Herpen; M Gotthardt; S Heskamp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-12       Impact factor: 9.236
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.